Through this work, we will focus on underlying, in 93 AML patients, the correlation between ALDH1A1/2 activity and leukaemic cells redox status, with the ELN 2002 classification at diagnosis, the therapeutic response and overall survival. This evidence concerns the gene ALDH1A1 and acute myeloid leukemia.